Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Lawrence

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
The Journal of Trauma|January 1, 1983
Treatment of open fractures: a prospective studyD R Benson, R S Riggins, R M Lawrence, et al.
Journal of Acquired Immune Deficiency Syndromes|October 1, 1993
HIV infection in Romanian children: a call for antiretroviral therapyE Leibovitz, D Cooper, S J Orlow, et al.
Annals of the New York Academy of Sciences|January 1, 1988
Treatment of fungal infections with semisynthetic derivatives of amphotericin B alphaP D Hoeprich, N M Flynn, M M Kawachi, et al.
Carcinogenesis|December 1, 1996
Monitoring of exposure to acrylonitrile by determination of N-(2-cyanoethyl)valine at the N-terminal position of haemoglobinR Tavares, H Borba, M Monteiro, et al.
The New England Journal of Medicine|August 16, 1979
An unusual outbreak of windborne coccidioidomycosisN M Flynn, P D Hoeprich, M M Kawachi, et al.
Journal of Medicinal Chemistry|July 7, 1995
1,1-Bisphosphonate squalene synthase inhibitors: interplay between the isoprenoid subunit and the diphosphate surrogateD R Magnin, S A Biller, J K Dickson, et al.
The Journal of Biological Chemistry|November 25, 1993
Lipophilic 1,1-bisphosphonates are potent squalene synthase inhibitors and orally active cholesterol lowering agents in vivoC P Ciosek, D R Magnin, T W Harrity, et al.
Journal of Medicinal Chemistry|February 2, 1996
alpha-Phosphonosulfonic acids: potent and selective inhibitors of squalene synthaseD R Magnin, S A Biller, Y Chen, et al.
Science (New York, N.Y.)|October 23, 1998
An MTP inhibitor that normalizes atherogenic lipoprotein levels in WHHL rabbitsJ R Wetterau, R E Gregg, T W Harrity, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
The Journal of Trauma|January 1, 1983
Treatment of open fractures: a prospective studyD R Benson, R S Riggins, R M Lawrence, et al.
Journal of Acquired Immune Deficiency Syndromes|October 1, 1993
HIV infection in Romanian children: a call for antiretroviral therapyE Leibovitz, D Cooper, S J Orlow, et al.
Annals of the New York Academy of Sciences|January 1, 1988
Treatment of fungal infections with semisynthetic derivatives of amphotericin B alphaP D Hoeprich, N M Flynn, M M Kawachi, et al.
Carcinogenesis|December 1, 1996
Monitoring of exposure to acrylonitrile by determination of N-(2-cyanoethyl)valine at the N-terminal position of haemoglobinR Tavares, H Borba, M Monteiro, et al.
The New England Journal of Medicine|August 16, 1979
An unusual outbreak of windborne coccidioidomycosisN M Flynn, P D Hoeprich, M M Kawachi, et al.
Journal of Medicinal Chemistry|July 7, 1995
1,1-Bisphosphonate squalene synthase inhibitors: interplay between the isoprenoid subunit and the diphosphate surrogateD R Magnin, S A Biller, J K Dickson, et al.
The Journal of Biological Chemistry|November 25, 1993
Lipophilic 1,1-bisphosphonates are potent squalene synthase inhibitors and orally active cholesterol lowering agents in vivoC P Ciosek, D R Magnin, T W Harrity, et al.
Journal of Medicinal Chemistry|February 2, 1996
alpha-Phosphonosulfonic acids: potent and selective inhibitors of squalene synthaseD R Magnin, S A Biller, Y Chen, et al.
Science (New York, N.Y.)|October 23, 1998
An MTP inhibitor that normalizes atherogenic lipoprotein levels in WHHL rabbitsJ R Wetterau, R E Gregg, T W Harrity, et al.
Pageof 6